We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Courtagen Life Sciences, Inc., an endocannabinoid platform and molecular information company, announced that the company has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application no.